Leadership – Serial Stage Venture Partners

Leadership

Founder & Managing Partner

Raymond Rackley MD, BME

Dr. Raymond Rackley is a renowned pelvic reconstructive surgeon who has also generated significant returns as a venture capitalist, while developing strong co-investing relationships with some of the region’s most active funders.

Currently, Dr. Rackley serves as a Professor of Surgery at the world’s premier Cleveland Clinic’s Glickman Urology Institute for Pelvic Medicine and Reconstructive Surgery. Over 32 years, he has become a leading biomedical engineer, reconstructive surgeon and life-science industry consultant.

He has also been an active investor, making numerous venture health science and technology investments since 2002 while serving as a board advisor, investment committee member or limited partner in Serial Stage Venture Partners, an angel investor network, and several Midwest venture funds including NDI Healthcare Fund and BioEnterprise’s Medical Growth Fund.

As an active investor/advisor, Dr. Rackley has participated in multiple co-investing and venture partnering activities alongside regional venture funders such as First Analysis, BioEnterprise, Queen City Angels, and MI-12 managing partners while holding board and committee roles in several seed-series, early and late stage medical device and pharmaceutical companies.

Dr. Rackley earned his MD in Medicine from Case Western Reserve University Medical School and his BS in Biomedical Engineering from Duke Engineering.

Managing Partner

Jonathan Lehman

Jonathan Lehmann is a MedTech leader, angel investor, and commercial consultant. He is a 20-year veteran of the space and is driven by the purpose of playing a role in the funding and commercializing of minimally-invasive, clinically-effective, financially-viable, and patient-centric ideas that benefit patients, providers, and payers.

He has sold, built salesforces, funded, and forged strategic partnerships in numerous markets from primary care to endocrine to cardiology to psychiatry to genetics to population health to sports medicine to regenerative health. But his sweetspot markets are ENT and Urology where he created scalable in office procedural models that fueled explosive growth against J&J, AMS, Smith & Nephew, and Medtronic leading to immense value creation for providers and companies during two liquidity events ENTL Nasdaq $70m IPO & subsequent $662m sale to Stryker.

In his spare time you can find him on the water talking business, foiling, or sharing his love for and the beauty that is the "Blue Mindset".

Managing Partner

Eric Ulchaker MS, MFin

Eric C. Ulchaker brings over a decade of entrepreneurial experience, including more than two years in venture capital, with a proven track record of successful ventures. He previously served as the Fund Manager for the Pit Road Fund, a $23 million pre-seed and seed-stage venture fund affiliated with the University of Notre Dame. Eric was instrumental in raising the 1842 Fund, a partnership between High Alpha Innovation and the University of Notre Dame, where he led diligence efforts on investments following the fund’s initial close at $17.5 million. Additionally, he was a Summer Associate with North Coast Ventures. Eric is an active angel investor.

Eric’s passion for MedTech, BioTech, and HealthTech began early in his career. As a sophomore specializing in Entrepreneurship and Commerce at Gilmour Academy in Gates Mills, Ohio, Eric worked with Pulmonary Apps, a Cleveland-based company that developed the digibreathe©, a wireless, patient-based, disposable, adhesive-backed, stethoscope monitoring pad. During his freshman year of college, he joined a HealthTech, telemedicine startup - Apportis, and was integral in securing a $200 thousand grant from the state of Ohio. He continues to serve as an advisor to the company. Eric worked in business development with Million Marker, a Y-Combinator-backed biomarker company in Berkeley, California, assisting them in establishing product-market fit for his capstone project at the University of Notre Dame.

Eric earned a Bachelor of Science in Business Administration with a specialization in Operations Management and a minor in Entrepreneurship and Innovation from The Ohio State University’s Fisher College of Business. He went on to complete a Master of Science in Engineering, Science, and Technology Commercialization from the University of Notre Dame and a Master of Finance in Corporate Finance from Case Western Reserve University’s Weatherhead School of Management.